Ep. 101 - Of Biotech Bears, Pazdur & PDUFA

BioCentury This Week

English - February 08, 2022 02:00 - 28 minutes - 19.7 MB - ★★★★★ - 11 ratings
Science biotech biopharma pharmaceutical research investment dealmaking Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep. 100 - Capital markets check in; plus Belgium’s prodigal son returns

Next Episode: Ep. 102 - What FDA's Tyvyt Precedent Means for China; plus Translational Trendspotting

Weathering the bear market. Oncology chief’s change in thinking on PD-1 therapies. Plus BioCentury’s 2021 innovative start-ups. This week’s podcast is sponsored by ICON.